The position involves designing and overseeing clinical research programs, building relationships with key opinion leaders, and applying their input to enhance study design and protocols. The role serves as a medical/scientific consultant to marketing or research project teams and government regulatory agencies, establishing criteria essential for determining safety, efficacy, and medical utilities. Responsibilities include interpreting results of Phase I-III investigations in preparation for new-drug or medical device applications, and may involve serving as a safety expert for individual clinical projects. The position also entails serving as the Clinical Development Representative on Biomedical Research (BR) clinical/project teams to drive the transition of pre-PoC (Proof of Concept) projects to Development Decision Point (DDP). The role supports Business Development & Licensing (BD&L) activities and leads the Global Clinical Team (GCT), representing Clinical Development on the Global Program Team (GPT). Post-Transition Development Point, the position leads the development and execution of the clinical strategy, developing an endorsed Integrated Development Plan (IDP) aligned with the Target Product Profile (TPP) for successful global regulatory approval and market access for one or multiple treatment indications and/or multiple programs. The role also involves leading the creation of clinical components of key documents with high quality and consistency with IDP and TPP, supporting registration, market access, commercialization, and maintenance of product licenses, and ensuring continuous evaluation of drug safety profiles.